BRIEF-Avenira Says Strategic Investment From Sichuan Hebang Biotechnology

Reuters07-30

July 30 (Reuters) - Avenira Ltd :

* STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY

* INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS

* AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM

* FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2455989424?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-30 18:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2455989424","market":null,"top_or_hot":-1,"title":"BRIEF-Avenira Says Strategic Investment From Sichuan Hebang Biotechnology","media":"Reuters","content":"<html><body><p>July 30 (Reuters) - Avenira Ltd   :</p><p>   * STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY</p><p>   * INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS</p><p>   * AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM</p><p>   * FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Avenira Says Strategic Investment From Sichuan Hebang Biotechnology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Avenira Says Strategic Investment From Sichuan Hebang Biotechnology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-30 18:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 30 (Reuters) - Avenira Ltd   :   * STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY   * INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AEV.AU","symbol_name":"AVENIRA LTD","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2455989424","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2455989424","pubTimestamp":1722335261,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 30  - Avenira Ltd   :   * STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY   * INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS   * AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM   * FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AEV.AU":"AVENIRA LTD"},"translate_title":"简介-Avenira表示四川和邦生物的战略投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AEV.AU":0.9},"content_text":"July 30 (Reuters) - Avenira Ltd   :   * STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY   * INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS   * AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM   * FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2455989424"}